drugs for schistosomiasis market

Global Drugs for Schistosomiasis Market Analysis 2016-2020 and Forecast 2021-2026

  • Published Date: 2021-02-15
  • Report ID: 53386
  • Pages: 84
  • Format: prudent report format

Snapshot

Schistosomiasis, also known as snail fever and bilharzia, is a disease caused by parasitic flatworms called schistosomes. The urinary tract or the intestines may be infected. Signs and symptoms may include abdominal pain, diarrhea, bloody stool, or blood in the urine. Those who have been infected a long time may experience liver damage, kidney failure, infertility, or bladder cancer. In children, it may cause poor growth and learning difficulty.
The global Drugs for Schistosomiasis market size is estimated at xxx million USD with a CAGR xx% from 2016-2020 and is expected to reach xxx Million USD in 2021 with a CAGR xx% from 2021 to 2026. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Drugs for Schistosomiasis by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.

Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Praziquantel
Oxamniquine
Others

Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):
Merck
Shin Poong
Bayer
EIPICO
Chandra Bhagat Pharma
Taj Pharmaceuticals

Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
S. haematobium
S. mansoni
S. japonicum
S. mekongi
S. intercalatum

Region Coverage (Regional Production, Demand & Forecast by Countries etc.):
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)


Table of Contents
1 Industry Overview
1.1 Drugs for Schistosomiasis Industry
Figure Drugs for Schistosomiasis Industry Chain Structure
1.1.1 Overview
1.1.2 Development of Drugs for Schistosomiasis
1.2 Market Segment
1.2.1 Upstream
Table Upstream Segment of Drugs for Schistosomiasis
1.2.2 Downstream
Table Application Segment of Drugs for Schistosomiasis
Table Global Drugs for Schistosomiasis Market 2016-2026, by Application, in USD Million
1.2.3 COVID-19 Impact
1.3 Cost Analysis
2 Industry Environment (PEST Analysis)
2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology
3 Drugs for Schistosomiasis Market by Type
3.1 By Type
3.1.1 Praziquantel
Table Major Company List of Praziquantel
3.1.2 Oxamniquine
Table Major Company List of Oxamniquine
3.1.3 Others
Table Major Company List of Others
3.2 Market Size
Table Global Drugs for Schistosomiasis Market 2016-2020, by Type, in USD Million
Figure Global Drugs for Schistosomiasis Market Growth 2016-2020, by Type, in USD Million
Table Global Drugs for Schistosomiasis Market 2016-2020, by Type, in Volume
Figure Global Drugs for Schistosomiasis Market Growth 2016-2020, by Type, in Volume
3.3 Market Forecast
Table Global Drugs for Schistosomiasis Market Forecast 2021-2026, by Type, in USD Million
Table Global Drugs for Schistosomiasis Market Forecast 2021-2026, by Type, in Volume
4 Major Companies List
4.1 Merck (Company Profile, Sales Data etc.)
4.1.1 Merck Profile
Table Merck Overview List
4.1.2 Merck Products & Services
4.1.3 Merck Business Operation Conditions
Table Business Operation of Merck (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.2 Shin Poong (Company Profile, Sales Data etc.)
4.2.1 Shin Poong Profile
Table Shin Poong Overview List
4.2.2 Shin Poong Products & Services
4.2.3 Shin Poong Business Operation Conditions
Table Business Operation of Shin Poong (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.3 Bayer (Company Profile, Sales Data etc.)
4.3.1 Bayer Profile
Table Bayer Overview List
4.3.2 Bayer Products & Services
4.3.3 Bayer Business Operation Conditions
Table Business Operation of Bayer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.4 EIPICO (Company Profile, Sales Data etc.)
4.4.1 EIPICO Profile
Table EIPICO Overview List
4.4.2 EIPICO Products & Services
4.4.3 EIPICO Business Operation Conditions
Table Business Operation of EIPICO (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.5 Chandra Bhagat Pharma (Company Profile, Sales Data etc.)
4.5.1 Chandra Bhagat Pharma Profile
Table Chandra Bhagat Pharma Overview List
4.5.2 Chandra Bhagat Pharma Products & Services
4.5.3 Chandra Bhagat Pharma Business Operation Conditions
Table Business Operation of Chandra Bhagat Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.6 Taj Pharmaceuticals (Company Profile, Sales Data etc.)
4.6.1 Taj Pharmaceuticals Profile
Table Taj Pharmaceuticals Overview List
4.6.2 Taj Pharmaceuticals Products & Services
4.6.3 Taj Pharmaceuticals Business Operation Conditions
Table Business Operation of Taj Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
5 Market Competition
5.1 Company Competition
Table Global Drugs for Schistosomiasis Sales Revenue 2016-2020, by Company, in USD Million
Table Global Drugs for Schistosomiasis Sales Revenue Share 2016-2020, by Company, in USD Million
Figure Global Drugs for Schistosomiasis Sales Revenue Share in 2020, by Company, in USD Million
Table Global Drugs for Schistosomiasis Sales Volume 2016-2020, by Company, in Volume
Table Global Drugs for Schistosomiasis Sales Volume Share 2016-2020, by Company, in Volume
Figure Global Drugs for Schistosomiasis Sales Volume Share in 2020, by Company, in Volume
5.2 Regional Market by Company
Figure North America Drugs for Schistosomiasis Market Concentration, in 2020
Figure Europe Drugs for Schistosomiasis Market Market Concentration, in 2020
Figure Asia-Pacific Drugs for Schistosomiasis MMarket Concentration, in 2020
Figure South America Drugs for Schistosomiasis Market Concentration, in 2020
Figure Middle East & Africa Drugs for Schistosomiasis Market Concentration, in 2020
6 Demand by End Market
6.1 Demand Situation
6.1.1 Demand in S. haematobium
Figure Drugs for Schistosomiasis Demand in S. haematobium, 2016-2020, in USD Million
Figure Drugs for Schistosomiasis Demand in S. haematobium, 2016-2020, in Volume
6.1.2 Demand in S. mansoni
Figure Drugs for Schistosomiasis Demand in S. mansoni, 2016-2020, in USD Million
Figure Drugs for Schistosomiasis Demand in S. mansoni, 2016-2020, in Volume
6.1.3 Demand in S. japonicum
Figure Drugs for Schistosomiasis Demand in S. japonicum, 2016-2020, in USD Million
Figure Drugs for Schistosomiasis Demand in S. japonicum, 2016-2020, in Volume
6.1.4 Demand in S. mekongi
Figure Drugs for Schistosomiasis Demand in S. mekongi, 2016-2020, in USD Million
Figure Drugs for Schistosomiasis Demand in S. mekongi, 2016-2020, in Volume
6.1.5 Demand in S. intercalatum
Figure Drugs for Schistosomiasis Demand in S. intercalatum, 2016-2020, in USD Million
Figure Drugs for Schistosomiasis Demand in S. intercalatum, 2016-2020, in Volume
6.2 Regional Demand Comparison
Table Regional Demand Comparison List
Table Major Application in Different Regions
6.3 Demand Forecast
Table Drugs for Schistosomiasis Demand Forecast 2021-2026, by Application, in USD Million
Figure Drugs for Schistosomiasis Market Growth 2021-2026, by Application, in USD Million
Figure Drugs for Schistosomiasis Market Share in 2026, by Application, in USD Million
Table Drugs for Schistosomiasis Demand Forecast 2021-2026, by Application, in Volume
Table Drugs for Schistosomiasis Market Growth 2021-2026, by Application, in Volume
Table Drugs for Schistosomiasis Market Share in 2026, by Application, in Volume
6.4 Impact of the COVID-19 on the Demand
7 Region Operation
7.1 Regional Production
Table Drugs for Schistosomiasis Production 2016-2020, by Region, in USD Million
Table Drugs for Schistosomiasis Production 2016-2020, by Region, in Volume
7.2 Regional Market
Table Global Drugs for Schistosomiasis Market 2016-2020, by Region, in USD Million
Table Global Drugs for Schistosomiasis Market Share 2016-2020, by Region, in USD Million
Table Global Drugs for Schistosomiasis Market 2016-2020, by Region, in Volume
Table Global Drugs for Schistosomiasis Market Share 2016-2020, by Region, in Volume
7.3 by Region
7.3.1 North America
7.3.1.1 Overview
Figure North America Drugs for Schistosomiasis Market Size and Growth 2016-2020, in USD Million
Figure North America Drugs for Schistosomiasis Market Size and Growth 2016-2020, in Volume
7.3.1.2 by Country (U.S., Canada, Mexico)
Table North America Drugs for Schistosomiasis Market Size 2016-2020, by Country, in USD Million
Table North America Drugs for Schistosomiasis Market Size 2016-2020, by Country, in Volume
7.3.2 Europe
7.3.2.1 Overview
Figure Europe Drugs for Schistosomiasis Market Size and Growth 2016-2020, in USD Million
Figure Europe Drugs for Schistosomiasis Market Size and Growth 2016-2020, in Volume
7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
Table Europe Drugs for Schistosomiasis Market Size 2016-2020, by Country, in USD Million
Table Europe Drugs for Schistosomiasis Market Size 2016-2020, by Country, in Volume
7.3.3 Asia-Pacific
7.3.3.1 Overview
Figure Asia-Pacific Drugs for Schistosomiasis Market Size and Growth 2016-2020, in USD Million
Figure Asia-Pacific Drugs for Schistosomiasis Market Size and Growth 2016-2020, in Volume
7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
Table Asia-Pacific Drugs for Schistosomiasis Market Size 2016-2020, by Country, in USD Million
Table Asia-Pacific Drugs for Schistosomiasis Market Size 2016-2020, by Country, in Volume
7.3.4 South America
7.3.4.1 Overview
Figure South America Drugs for Schistosomiasis Market Size and Growth 2016-2020, in USD Million
Figure South America Drugs for Schistosomiasis Market Size and Growth 2016-2020, in Volume
7.3.4.2 by Country (Brazil, Argentina etc.)
Table South America Drugs for Schistosomiasis Market Size 2016-2020, by Country, in USD Million
Table South America Drugs for Schistosomiasis Market Size 2016-2020, by Country, in Volume
7.3.5 Middle East & Africa
7.3.5.1 Overview
Figure Middle East & Africa Drugs for Schistosomiasis Market Size and Growth 2016-2020, in USD Million
Figure Middle East & Africa Drugs for Schistosomiasis Market Size and Growth 2016-2020, in Volume
7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
Table Middle East & Africa Drugs for Schistosomiasis Market Size 2016-2020, by Country, in USD Million
Table Middle East & Africa Drugs for Schistosomiasis Market Size 2016-2020, by Country, in Volume
7.4 Regional Import & Export
7.5 Regional Forecast
Table Drugs for Schistosomiasis Market Forecast 2021-2026, by Region, in USD Million
Table Drugs for Schistosomiasis Market Forecast 2021-2026, by Region, in Volume
8 Marketing & Price
8.1 Price and Margin
8.1.1 Price Trends
8.1.2 Factors of Price Change
Table Price Factors List
8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel
Figure Marketing Channels Overview
9 Research Conclusion
CHOOSE LICENCE TYPE
prudent payment methods
Contact Us

Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071

Drop us an email at
sales@prudentmarkets.com

Why Choose Us
24 * 7 Access to Analyst :

Get your pre and post sales queries resolved by our Subject matter experts.

Customization :

We will assist you to customize the report to fit your research needs.

Assured Quality :

Our prime focus is to provide qualitative and accurate data.

Free sample report :

Feel free to order a sample report before purchase.

Security :

Your personal and confidential information is safe and secured.